Maintenance Poly (ADP-ribose) Polymerase Inhibitor Therapy for Ovarian Cancer: Precision Oncology or One Size Fits All?

Authors :: Berchuck A
Secord AA
Moss HA
Havrilesky LJ
Source :: Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2017 Dec 20; Vol. 35 (36), pp. 3999-4002. Date of Electronic Publication: 2017 Oct 26.
Publication Year :: 2017

Subjects :: Clinical Decision-Making
Cost-Benefit Analysis
Drug Costs
Female
Genetic Predisposition to Disease
Humans
Maintenance Chemotherapy
Ovarian Neoplasms economics
Ovarian Neoplasms enzymology
Ovarian Neoplasms genetics
Phenotype
Poly(ADP-ribose) Polymerase Inhibitors adverse effects
Poly(ADP-ribose) Polymerase Inhibitors economics
Biomarkers, Tumor genetics
Genetic Variation
Ovarian Neoplasms drug therapy
Poly(ADP-ribose) Polymerase Inhibitors therapeutic use
Precision Medicine economics

Language :: English
ISSN :: 1527-7755
Volume :: 35
Issue :: 36
Database :: MEDLINE
Journal :: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Publication Type :: Academic Journal
Accession number :: 29072978
Full Text :: https://doi.org/10.1200/JCO.2017.74.5752

Full Text Access

Tools